Note: This article is educational and is based on current prescribing information, pregnancy registry data, lactation references, and clinical guidance for inflammatory and immune-mediated diseases. It is not medical advice. People who are pregnant, planning pregnancy, breastfeeding, or considering medication changes should speak with their prescribing clinician, OB-GYN, gastroenterologist, dermatologist, rheumatologist, and pediatrician.
Pregnancy already comes with enough questions to fill a shopping cart: Can I eat this cheese? Why do I suddenly hate coffee? Is that symptom normal, weird, or “call the doctor now” weird? Add a biologic medication like Stelara to the mix, and the questions become even more serious.
Stelara, the brand name for ustekinumab, is a prescription biologic used to treat several immune-related conditions, including moderate to severe plaque psoriasis, active psoriatic arthritis, Crohn’s disease, and ulcerative colitis. Because many people take Stelara during their reproductive years, it is completely reasonable to ask: Is Stelara safe during pregnancy? Can you breastfeed while using Stelara? What about fertility, vaccines, and the baby’s immune system?
The short answer is cautiously reassuring, but not casual. Current human data have not identified a clear Stelara-associated risk of major birth defects, miscarriage, or adverse infant outcomes. At the same time, data are still more limited than they are for older medications. That means the best decision is rarely “always take it” or “always stop it.” It is usually a personalized risk-benefit conversation built around disease control, timing, pregnancy plans, and infant care.
What Is Stelara?
Stelara is a biologic medication that targets two immune system proteins: interleukin-12 and interleukin-23. These proteins help drive inflammation in certain autoimmune and immune-mediated diseases. By blocking them, Stelara can reduce inflammation that affects the skin, joints, and digestive tract.
In plain English, Stelara tells an overexcited immune system to stop acting like a smoke alarm that goes off every time someone makes toast. It does not “turn off” the immune system completely, but it does adjust immune activity. That is why infection risk, vaccines, pregnancy, and breastfeeding need thoughtful discussion.
Conditions Stelara May Treat
Stelara is used for several conditions, including:
- Moderate to severe plaque psoriasis in adults and children who meet age and treatment criteria
- Active psoriatic arthritis in adults and eligible pediatric patients
- Moderately to severely active Crohn’s disease in adults and eligible children
- Moderately to severely active ulcerative colitis in adults
The reason for taking Stelara matters during pregnancy planning. Someone using it for Crohn’s disease may have different risks from stopping treatment than someone using it for skin symptoms that are currently mild. The medication question is never floating alone in space; it is tied to the condition being treated.
Stelara and Pregnancy: What Current Evidence Suggests
Current available data from pregnancy registries, published studies, and postmarketing reports have not identified a Stelara-related pattern of major birth defects, miscarriage, or adverse pregnancy outcomes. That is encouraging. However, “encouraging” is not the same as “we know everything.” Pregnancy research with biologics often involves smaller numbers than researchers would like, because pregnant people are usually excluded from traditional drug trials.
The official safety language remains careful: it is not fully known whether Stelara can harm an unborn baby. That wording can sound scary, but it is common for medications with limited pregnancy trial data. What matters is balancing the known and potential risks of the drug against the known risks of uncontrolled inflammatory disease.
Why Disease Control Matters
For people with inflammatory bowel disease, active disease during pregnancy is associated with higher risks such as preterm birth, low birth weight, and babies who are small for gestational age. In other words, stopping an effective medication can sometimes create more risk than continuing it. A quiet disease is often the pregnancy guest everyone wants: boring, predictable, and not starting drama at 2 a.m.
For psoriasis and psoriatic arthritis, the picture can vary. Some people improve during pregnancy, while others flare. Joint inflammation, severe skin disease, pain, sleep disruption, and the need for rescue steroids can all affect quality of life and pregnancy care. That is why doctors often focus on maintaining stable disease before conception and throughout pregnancy rather than making sudden medication changes after a positive pregnancy test.
Placental Transfer: Can Stelara Reach the Baby?
Stelara is an IgG1 monoclonal antibody. IgG antibodies can cross the placenta, and transfer generally increases as pregnancy progresses, especially in the third trimester. This means a baby exposed in the womb may have some Stelara in their system at birth.
That does not automatically mean harm. Many biologic medicines can cross the placenta, and exposure alone is not the same thing as a bad outcome. However, it does matter for planning infant vaccines, especially live vaccines. If you use Stelara during pregnancy, your pediatrician should know before the baby arrives. Add it to the birth plan right next to “please explain things clearly” and “no one touch the hospital bag snacks.”
Should You Stop Stelara Before Getting Pregnant?
Do not stop Stelara on your own if you are planning pregnancy. This is one of those moments where “I read something online and made a medication decision at midnight” can backfire spectacularly.
Instead, ask your healthcare team these questions:
- How stable is my disease right now?
- What is my risk of flare if I stop or delay Stelara?
- Are there safer or better-studied alternatives for my condition?
- What trimester timing makes sense for my dosing schedule?
- How should we coordinate care between specialists and my OB-GYN?
For some patients, continuing Stelara may be the best option because it keeps disease controlled. For others, a clinician may adjust timing, switch therapies, or create a monitoring plan. The decision depends on diagnosis, disease severity, prior flares, previous medication failures, pregnancy history, and personal preferences.
What If You Become Pregnant While Taking Stelara?
If you find out you are pregnant while on Stelara, contact your healthcare provider. Do not panic. Current evidence has not shown a clear signal of major pregnancy harm, and many people have had healthy pregnancies after exposure. The next step is to review your timing, your disease status, and your treatment plan.
Your clinician may discuss whether to continue treatment, whether to adjust the dosing schedule later in pregnancy, and whether additional monitoring is needed. The goal is not to win a purity contest by taking the fewest medications. The goal is a healthy parent, a healthy baby, and inflammation that behaves itself.
Stelara and Breastfeeding
Breastfeeding while taking Stelara is another common question. Available information suggests that ustekinumab may appear in breast milk in small amounts. Because Stelara is a large protein molecule and is not expected to be well absorbed through a baby’s digestive tract, the amount that reaches the infant’s bloodstream is likely low.
Several lactation references and clinical experiences are reassuring, and no consistent pattern of harmful effects in breastfed infants has been causally linked to Stelara. Still, the data are limited, so breastfeeding decisions should consider the mother’s medical need for treatment, the benefits of breastfeeding, the baby’s health, and whether the infant was premature or medically fragile.
Do You Need to “Pump and Dump”?
For many biologics used in inflammatory bowel disease, experts no longer recommend timing breastfeeding around medication doses or “pumping and dumping” as a routine strategy. Breast milk levels are generally low, and throwing away milk after a dose may not provide meaningful benefit.
That said, every case deserves individual care. A healthy full-term infant is different from a premature newborn in the NICU. A parent in deep remission is different from a parent at high risk of a severe flare. When in doubt, your prescribing specialist and pediatrician can help you decide what is reasonable.
Restarting Stelara After Delivery
Some clinicians may discuss waiting briefly after delivery before restarting a biologic if it was paused during pregnancy. This is sometimes done to minimize transfer into early breast milk, though the right timing depends on disease risk. For someone likely to flare, delaying treatment may not be worth it. Postpartum flares are not cute. They do not care that you are already sleep-deprived and wearing a shirt with mysterious milk stains.
Stelara, Fertility, and Trying to Conceive
There is no strong evidence that Stelara reduces female fertility. In many cases, the underlying disease may be more relevant to fertility than the medication itself. Active Crohn’s disease, pelvic inflammation, poor nutrition, severe systemic inflammation, and prior surgeries can all affect fertility or pregnancy planning.
For men or sperm-producing partners, limited available data have not shown a clear increase in birth defects or miscarriage linked to paternal ustekinumab exposure. In general, medication exposures fromekinumab exposure. In general, medication exposures from the father or sperm donor are less likely to increase pregnancy risks than direct exposure during pregnancy. However, anyone trying to conceive should review medications with a healthcare professional, especially if they take multiple immune-modifying drugs.
Vaccines, Infections, and Baby Planning
Stelara can increase the risk of infections and may reactivate certain latent infections. Before starting treatment, patients are commonly evaluated for tuberculosis. During treatment, people should contact their doctor if they develop signs of infection such as fever, persistent cough, painful skin changes, shortness of breath, burning urination, or shingles-like rash.
Vaccines also deserve attention. People receiving Stelara should generally avoid live vaccines during treatment. The BCG vaccine is a special concern and has specific timing restrictions. In the United States, BCG is not routinely given to most infants, but it may matter for families who travel or live in countries where BCG is used.
Infant Vaccines After Stelara Exposure in Pregnancy
If a baby was exposed to Stelara in the womb, especially during the third trimester, parents should tell the pediatrician before any live vaccine is given. Some expert guidance recommends delaying live vaccines for infants exposed to biologics in utero, commonly for the first six months, depending on the medication and exposure timing.
This is especially important because the rotavirus vaccine is a live oral vaccine given early in infancy in the United States. Timing rules for rotavirus vaccination are strict, so the pediatrician should know about Stelara exposure before the first well-baby visits. Inactivated vaccines, such as many routine childhood vaccines, are generally handled differently, but your pediatrician should make the final call.
Stelara Side Effects to Watch For During Pregnancy or Postpartum
Many side effects of Stelara are similar whether or not someone is pregnant. Commonly reported issues include upper respiratory infections, headache, tiredness, sore throat, nasal symptoms, and injection-site reactions. Serious side effects are less common but need urgent attention.
Call a healthcare provider promptly if you develop symptoms of a serious infection, allergic reaction, persistent cough, shortness of breath, severe headache, seizures, confusion, or vision changes. Pregnancy can make symptom sorting harder because some discomforts overlap with normal pregnancy changes. When unsure, call. Your care team would rather answer a cautious question than miss something important.
Questions to Ask Your Doctor About Stelara and Pregnancy
Before conception or as soon as pregnancy is confirmed, consider bringing a written list of questions to your appointment. Pregnancy brain is real, and even very organized people can forget half their questions the moment the exam room paper crinkles.
- Is my condition controlled well enough to try for pregnancy?
- Should I continue Stelara during conception and pregnancy?
- Would stopping Stelara increase my risk of flare, steroid use, hospitalization, or surgery?
- Should my dose timing change in the third trimester?
- What monitoring do I need during pregnancy?
- Can I breastfeed while using Stelara?
- What should my baby’s pediatrician know about live vaccines?
- Are there other medications, supplements, or vaccines I should update before pregnancy?
Practical Planning Tips for Patients Using Stelara
1. Build a Team Before You Need One
The best pregnancy plans are made before a flare, not during one. Ideally, your OB-GYN and specialist should communicate early. For IBD, a gastroenterologist and maternal-fetal medicine specialist may be involved. For psoriasis or psoriatic arthritis, a dermatologist or rheumatologist may help guide therapy.
2. Aim for Remission Before Conception
If possible, many specialists prefer patients to enter pregnancy with disease controlled for several months. This is especially important in Crohn’s disease and ulcerative colitis, where active inflammation can increase pregnancy risks.
3. Keep a Medication Timeline
Write down your Stelara dose dates, any missed doses, flares, infections, steroids, antibiotics, and pregnancy milestones. This helps clinicians make better decisions and prevents the classic “I know I took it on a Tuesday… possibly in March… or was that my dentist appointment?” moment.
4. Plan for Postpartum Care
After delivery, sleep loss, hormonal changes, stress, and medication interruptions can all affect inflammatory disease. Make a postpartum plan before the baby arrives. Include breastfeeding goals, medication timing, flare symptoms, emergency contacts, and follow-up appointments.
Experiences Related to Stelara and Pregnancy, Breastfeeding, and More
The experiences below are composite examples based on common patient concerns. They are not real patient stories, and they should not replace medical advice. Their purpose is to show how conversations about Stelara, pregnancy, breastfeeding, and immune-related disease often unfold in everyday life.
Experience 1: “I Was Stable, and That Changed the Conversation”
A patient with Crohn’s disease had been on Stelara for more than a year and had finally reached remission. Before Stelara, she had frequent abdominal pain, urgent bathroom trips, anemia, and several rounds of steroids. When she started planning pregnancy, her first instinct was to stop every medication. It felt “cleaner.” But after talking with her gastroenterologist and OB-GYN, she realized that uncontrolled Crohn’s disease could pose real risks during pregnancy.
Her doctors explained that staying in remission was one of the most important goals. Together, they reviewed the available safety data, discussed dose timing, and made a plan for monitoring. Her biggest relief came from understanding that pregnancy care was not about choosing between herself and the baby. Keeping her disease controlled was part of protecting both.
Experience 2: “Breastfeeding Felt Like One More Test”
Another parent used Stelara for severe plaque psoriasis and psoriatic arthritis. During pregnancy, her skin improved, but joint pain returned late in the third trimester. After delivery, she wanted to breastfeed but worried that Stelara in breast milk might harm the baby. Her pediatrician and dermatologist explained that only limited amounts are expected in milk and that the baby’s digestive system is unlikely to absorb much of the medication.
That conversation helped her move from fear to a practical plan. She watched the baby for infections, kept pediatric visits, and continued discussing symptoms with her own doctor. Breastfeeding was not magically easythere were latch issues, cluster feeding, and one memorable 3 a.m. crying session involving both baby and parentbut the medication question became manageable.
Experience 3: “The Vaccine Conversation Needed to Happen Early”
A third family learned that biologic exposure during pregnancy could affect live vaccine timing for the baby. They had not thought about vaccines beyond the standard schedule. Their OB-GYN suggested telling the pediatrician about Stelara exposure before delivery. This helped the pediatrician review the infant vaccine plan, especially live vaccines such as rotavirus.
The practical lesson was simple: do not wait until the baby’s two-month visit to mention medication exposure. Put it in the newborn record, tell the pediatrician, and ask specifically about live vaccines. It is much easier to plan ahead than to untangle confusion later while holding a diaper bag, a crying baby, and a coffee that has somehow become cold despite being purchased nine minutes ago.
Experience 4: “Stopping Was Not Automatically Safer”
Some patients assume that stopping a biologic is always safer during pregnancy. For certain drugs, that may be true. For Stelara, the decision is more nuanced. One patient with ulcerative colitis stopped medication without telling her doctor because she was afraid of harming the baby. Within weeks, symptoms returned. She needed steroids, extra monitoring, and urgent appointments during what she had hoped would be a calm first trimester.
Her experience highlights a key point: untreated inflammation is also an exposure. So are steroids, malnutrition, dehydration, hospitalization, and stress. Medication decisions should compare real options, not an imaginary medication-free world where the disease politely stays quiet.
Final Thoughts
Stelara and pregnancy is not a one-size-fits-all topic. Current evidence is reassuring overall, especially for people who need Stelara to keep Crohn’s disease, ulcerative colitis, psoriasis, or psoriatic arthritis controlled. Available data have not identified a clear Stelara-associated risk of major birth defects or miscarriage, and breastfeeding data suggest low transfer into milk with minimal expected absorption by the infant.
Still, decisions should be individualized. The right plan depends on disease severity, pregnancy timing, medication history, flare risk, breastfeeding goals, and infant vaccine planning. The best next step is not panic and not guesswork. It is a calm, detailed conversation with the clinicians who know your health history.
If there is one takeaway, make it this: for many people, controlling inflammatory disease is part of a healthy pregnancy plan. Stelara may be one tool in that plan, but it should be used with expert guidance, thoughtful monitoring, and clear communication between every member of the care team.
